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B I O C H E M I S T R Y
A matricellular protein fibulin-4 is essential 
for the activation of lysyl oxidase
Kazuo Noda1,2*, Kaori Kitagawa1*, Takao Miki1, Masahito Horiguchi3, Tomoya O. Akama1, 
Takako Taniguchi4, Hisaaki Taniguchi4, Kazuaki Takahashi5, Yasumitsu Ogra5,  
Robert P. Mecham6, Masahiko Terajima7, Mitsuo Yamauchi7, Tomoyuki Nakamura1†
Fibulin-4 is a matricellular protein required for extracellular matrix (ECM) assembly. Mice deficient in fibulin-4 
(Fbln4−/−) have disrupted collagen and elastin fibers and die shortly after birth from aortic and diaphragmatic 
rupture. The function of fibulin-4 in ECM assembly, however, remains elusive. Here, we show that fibulin-4 is re-
quired for the activity of lysyl oxidase (LOX), a copper-containing enzyme that catalyzes the covalent cross-linking 
of elastin and collagen. LOX produced by Fbln4−/− cells had lower activity than LOX produced by wild-type cells 
due to the absence of lysine tyrosyl quinone (LTQ), a unique cofactor required for LOX activity. Our studies showed 
that fibulin-4 is required for copper ion transfer from the copper transporter ATP7A to LOX in the trans-Golgi net-
work (TGN), which is a necessary step for LTQ formation. These results uncover a pivotal role for fibulin-4 in the 
activation of LOX and, hence, in ECM assembly.
INTRODUCTION
Elastic fibers and collagen fibers are the major extracellular matrices 
(ECMs) that confer resilience and tensile strength on tissues, re-
spectively. Elastic fibers are assembled from elastin protein aggre-
gates deposited onto microfibrils (1), and collagen fibers consist of 
bundles of collagen fibrils that are formed by the self-assembly of 
triple-helical collagen molecules (2). Both elastin and collagen fi-
bers undergo extensive lysine-derived cross-linking outside the cell 
to form the stable polymers that define their functional forms. Al-
though elastin and collagens do not share similar sequences, the 
cross-linking of both proteins is initiated by the same enzyme, lysyl 
oxidase (LOX) (3, 4).
LOX is a member of a copper amine oxidase family that includes 
LOX and LOX-like (LOXL) 1 to 4. LOX family members contain a 
highly conserved catalytic domain with a lysine tyrosyl quinone 
(LTQ) redox cofactor and a conserved copper-binding site in the 
C-terminal half of the protein (5, 6). The N-terminal domains are 
variable in length and sequence, and those of LOX and LOXL1 
function as propeptides, as they are proteolytically cleaved to release 
active enzyme (7). The propeptides are considered to function in 
secretion and distribution of the enzymes, suppression of the enzyme 
activity until proteolytically removed, or modulation of cell signaling 
(8, 9). LOXL2 to LOXL4 comprise a subfamily whose N-terminal 
domains contain scavenger receptor cysteine-rich domains, the func-
tion of which is not well understood (8). Mice deficient in LOX (Lox−/−) 
show defective cross-linking of elastin and collagen that leads to severe 
aortic aneurysm and emphysematous lungs and die perinatally due 
to aortic and diaphragmatic rupture (10, 11). In contrast, mice defi-
cient in either of LOXL1 to LOXL3 survive to adulthood and show 
much less severe phenotypes than Lox−/− mice (12–14). Mice defi-
cient in LOXL4 have not been reported. Therefore, LOX is consid-
ered to be the enzyme that plays a major role in cross-linking elastin 
and collagen, at least in the developmental stage.
The LOX enzyme is activated extracellularly when the propep-
tide is proteolytically removed from the proenzyme (proLOX) by 
the proteases bone morphogenetic protein 1 (BMP-1) or mammali-
an Tolloid-like 1 (mTLL-1), resulting in release of the catalytically 
active mature LOX (fig. S1, A and C) (15). Both copper binding and 
LTQ formation, which occur in the trans-Golgi network (TGN), are 
required for full enzyme activity. Copper binding to key histidine 
residues in LOX facilitates the formation of LTQ, an intramolecular 
cross-link between Lys314 and Tyr349 side chains (in the case of mu-
rine LOX) (fig. S1B) (5).
The fibulins are a family of matricellular proteins that function 
in the ECM but do not play a structural role (16). Fibulin-4, along 
with its closely related paralog fibulin-5, plays an essential role in 
elastogenesis. Mice deficient in fibulin-5 (Fbln5−/−) survive to adult-
hood, but exhibit severe emphysema, stiff and tortuous arteries, and 
loose skin, due to defective elastogenesis (17, 18). Collagen fibers 
are not affected, and aneurysms are not found in these mice. Mice 
deficient in fibulin-4 (Fbln4−/−), in contrast, show phenotypes that 
closely overlap with those of Lox−/− mice, including perinatal lethality 
due to aortic and diaphragmatic rupture, severe aortic aneurysms, 
and emphysematous lungs, with severely disrupted elastic fibers and 
abnormal collagen fibers (19, 20). These phenotypic similarities sug-
gest a functional link between fibulin-4 and LOX. Our previous data 
showed that the LOX propeptide interacts with fibulin-4, but not 
with fibulin-5 (17, 21). However, whether fibulin-4 is necessary for 
LOX activity has been elusive.
To elucidate whether and how fibulin-4 influences LOX activity, 
we explored the nature of LOX produced in the absence of fibulin-4. 
Here, we report that LOX secreted from Fbln4−/− cells is inactive 
due to the inability of LOX to form the LTQ cofactor. We show that 
fibulin-4 is required for copper ion transfer from the copper trans-
porter ATP7A to proLOX in the lumen of TGN. We also report that 
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secreted fibulin-4 can be internalized by endocytosis and contribute 
to the activation of LOX in the TGN. These results establish a pivot-
al role for fibulin-4 as an indispensable partner of LOX for its enzy-
matic activity.
RESULTS
The N-terminal domain of fibulin-4 is required 
for interaction with proLOX
A homozygous N-terminal missense mutation in the human FBLN4 
gene (E57K) was reported to cause cutis laxa syndrome, with as-
cending aortic aneurysms, arterial tortuosity, emphysema, and joint 
laxity (22). Because we previously showed that fibulin-4 interacts 
with the propeptide domain of proLOX (21), we examined whether 
the interaction between the two proteins is affected by mutation or 
truncation within the N-terminal region of fibulin-4. We used an 
in vitro binding assay using fibulin-4 mutants and proLOX overex-
pressed by 293T engineered by CRISPR-Cas9–based gene targeting 
to inactivate BMP-1 and avoid propeptide cleavage. The results con-
firmed that the interaction between the two proteins is largely de-
pendent on the N-terminal domain of fibulin-4, as proLOX did not 
coprecipitate with N-terminal fibulin-4 deletion mutants (∆N1 and 
∆N2). Similarly, the E57K mutant of fibulin-4 reacted only weakly 
with proLOX (Fig. 1).
LOX produced in the absence of fibulin-4 has altered 
posttranslational modification
To examine whether loss of fibulin-4 affects LOX protein in vivo, 
we performed Western blot analyses with an anti-LOX antibody of 
mouse neonatal aortic tissue extract. We detected only mature LOX 
enzyme without the propeptide; no proLOX was detectable in these 
tissues. Levels of mature LOX in Fbln4−/− tissues were comparable 
to those in wild-type (WT) aorta (Fig. 2A). However, mature LOX 
from Fbln4−/− aortic tissues, but not from Fbln5−/− aortic tissues, 
migrated slightly slower in SDS–polyacrylamide gel electrophoresis 
(SDS-PAGE) than LOX from WT aortic tissues (Fig. 2A).
This mobility shift was also evident in cell culture experiments 
where endogenously expressed LOX secreted into the culture medi-
um of Fbln4−/− mouse embryonic fibroblasts (MEFs) migrated in 
SDS-PAGE slower than that from WT MEFs (Fig. 2, B and C). Len-
tiviral expression of full-length WT fibulin-4 in Fbln4−/− MEFs 
reversed the mobility shift, with secreted LOX running at a size equiv-
alent to the WT protein. Lentiviral expression of fibulin-4 with the 
E57K mutation only partially rescued the mobility shift of LOX, and 
no rescue was observed with N-terminal deletion mutant of fibulin-4 
or full-length fibulin-5 (Fig. 2, B and C). LOX-FLAG secreted from 
Fbln4−/− MEFs infected with a lentivirus expressing C-terminally 
FLAG-tagged proLOX complementary DNA (cDNA) also exhibited 
delayed migration, indicating that the mobility shift was caused by 
altered posttranslational modification and not by alternative splicing 
(Fig. 2, D and E).
Fibulin-4 is necessary for LOX enzymatic activity
To explore the functional differences between the two forms of LOX, 
we purified endogenously expressed LOX from the conditioned me-
dium of WT and Fbln4−/− MEFs (Fig. 3A) and measured LOX enzy-
matic activity using tritiated tropoelastin as a substrate. LOX from 
Fbln4−/− MEFs was substantially less active than an equivalent amount 
of WT LOX (Fig. 3B). Consistent with this finding, levels of des-
mosine and isodesmosine, LOX-derived cross-links in elastin, and 
pyridinoline, a cross-link in collagen, were greatly reduced in neona-
tal aortae of both Fbln4−/− and Lox−/− mice compared to WT neonatal 
mouse aortae (Fig. 3, C and D). These results indicate that fibulin-4 is 
essential for the full enzymatic activity of LOX in vitro and in vivo.
Fibulin-4 is necessary for LTQ formation in LOX
There are four known posttranslational modifications of proLOX: 
glycosylation of the propeptide (23), cleavage of the propeptide (24), 
sulfation of tyrosine residues in LOX enzyme domain (25), and LTQ 
formation after copper ion binding (5). Because all potential glyco-
sylation sites are within the propeptide (23), this modification can-
not cause the mobility shift of mature LOX enzyme after cleavage of 
the propeptide. We then examined whether the cleavage site of 
proLOX differs between WT and Fbln4−/− cells. The N-terminal 
sequences of mature LOX purified from the conditioned medium of 
WT and Fbln4−/− MEFs were analyzed by Edman degradation. There 
was no difference in amino acid sequence between the genotypes, 
indicating that the mobility shift of LOX produced by Fbln4−/− cells 
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Fig. 1. An in vitro binding assay showing a domain-specific binding of fibulin-4 
(FBLN4) with proLOX. (A) Domain structure of FLAG-tagged full-length fibulin-4 
and fibulin-4 mutants (E57K, N1, and N2) and Myc-tagged proLOX used in the 
assay. (B) In vitro binding assay using the conditioned medium from 293T (BMP1−/−) 
cells transfected with plasmids encoding the cDNAs shown in (A). The lysates were 
mixed and immunoprecipitated with anti-FLAG agarose beads, followed by SDS-PAGE 
and Western blotting using anti-Myc and anti-FLAG antibodies (Ab). Note strong 
binding of proLOX with WT fibulin-4, while the binding was much weaker with 
E57K mutant fibulin-4 and even weaker with N-terminal deletion mutants.
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was not caused by an alternative propeptide cleavage site (fig. S1C). 
Similarly, the sulfation of LOX tyrosine residues does not account 
for the mobility shift, because YF mutant of LOX, in which poten-
tially sulfated tyrosine residues were substituted by phenylalanine 
residues (25), showed a mobility shift similar to WT LOX when pro-
duced by Fbln4−/− MEFs (fig. S2).
To examine whether the LOX mobility shift was related to loss of 
LTQ formation, we mutated the lysine (K314A) or tyrosine (Y349A) 
residues that form LTQ. Figure 4A shows that either mutation in-
troduced into LOX caused delayed migration by SDS-PAGE similar 
to that found with LOX produced by Fbln4−/− cells. Thus, the failure 
to form LTQ can cause the mobility shift. Quinoproteins are detect-
ed by staining with nitro blue tetrazolium (NBT), which is reduced 
to a colored formazan by the redox-cycling property of quinones 
(26). LOX purified from conditioned medium of WT MEFs, sepa-
rated by SDS-PAGE and electroblotted to a membrane, was intensely 
stained by NBT. In contrast, staining of LOX produced by Fbln4−/− 
MEFs was largely diminished, suggesting that the latter contains 
much less LTQ (Fig. 4, B and C). Furthermore, LOX from Fbln4−/− 
MEFs appeared as two bands by amido black staining of the mem-
brane, but only the minor lower band was stained by NBT (Fig. 4C). 
These data suggest that the lower band corresponds to LTQ-containing 
LOX, whereas the upper band is LOX that lacks LTQ. To directly 
measure LTQ levels, purified LOX was labeled with phenylhydrazine 
and digested with trypsin/Lys-C and Asp-N to generate the LTQ 
cross-link–containing peptide. Orbitrap mass spectrometric analysis 
(fig. S3) showed that the level of cross-linked peptide in the digest of 
LOX secreted from Fbln4−/− MEFs was markedly reduced compared 
to that in the digest of LOX secreted from WT MEFs (Fig. 4D). 
Together, these results indicate that fibulin-4 plays a necessary role 
in the formation of LTQ in LOX.
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Fig. 2. Mobility shift of LOX produced in the absence of fibulin-4 in SDS-PAGE. 
(A) Western blot analysis with anti-LOX antibody (left) and amido black staining of 
the same membrane (right) of mouse neonatal aortic tissue lysate (a pup/lane) of 
the indicated genotype. Note that LOX from Fbln4−/− aortic tissues migrated slightly 
slower than that from WT and Fbln5−/− tissues (open arrowheads). (B) Western blot 
analysis of LOX endogenously expressed by WT and Fbln4−/− MEFs. Note the dis-
tinct effects of lentiviral overexpression of HA-tagged fibulin-4 (HA-FBLN4 WT), 
E57K mutant fibulin-4 (HA-FBLN4 E57K), N-terminally deleted fibulin-4 (HA-FBLN4 
N1), and full-length fibulin-5 (HA-FBLN5) on LOX migration. (C) Ratio of the quan-
tified intensity of lower and upper bands of LOX. (D) Western blot analysis of over-
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LOX from WT and Fbln4−/− MEFs. Bar graphs show mean ± SEM (n = 4). **P < 0.01. 
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Fibulin-4 promotes copper ion transfer from copper 
transporter ATP7A to proLOX
LTQ formation involves copper ion bound to specific histidine res-
idues in proLOX (5). Copper loading occurs in the TGN and is de-
pendent on the transfer of copper from the cytoplasm to proLOX in 
the lumen of the TGN by the copper transporter ATP7A (fig. S1A) 
(5, 6). Therefore, we determined whether deficient LTQ formation 
in LOX produced by Fbln4−/− cells was due to reduced copper ion 
incorporation into proLOX. Endogenously expressed LOX from 
Atp7a−/− MEFs showed delayed migration in SDS-PAGE relative to 
LOX from WT MEFs, which was reversed by lentiviral expression 
of ATP7A (Fig. 5, A and B). Overexpressed LOX-FLAG from Atp7a−/− 
MEFs also showed delayed migration in SDS-PAGE similar to that 
from Fbln4−/− MEFs (Fig. 5C). In addition, LOX mutants in which 
copper-binding histidine residues were substituted by alanine resi-
dues to block copper binding showed similar mobility shift in SDS-
PAGE, even when they were expressed by WT MEFs (Fig. 5D). Last, 
we measured copper ion bound to LOX purified from the culture 
medium of WT MEFs and Fbln4−/− MEFs, using inductively cou-
pled plasma–mass spectrometry (ICP-MS). We found that copper 
ion bound to LOX produced by Fbln4−/− MEFs was markedly re-
duced compared to that produced by WT MEFs (Fig. 5E). These 
data suggest that loss of fibulin-4 causes a deficiency in copper ion 
incorporation into LOX, which results in defective LTQ formation.
To explore the mechanism by which fibulin-4 influences copper 
ion transfer from ATP7A to proLOX, we performed an in vitro bind-
ing assay using recombinant hemagglutinin (HA)–tagged fibulin-4 
and FLAG-tagged ATP7A overexpressed by 293T cells. Our results 
showed interaction between the two proteins (Fig. 5F). Both the 
N-terminal and C-terminal FLAG-tagged halves of ATP7A inter-
acted with HA-tagged fibulin-4 (fig. S4), suggesting that there are 
multiple binding sites for fibulin-4 within ATP7A. Protein mapping 
studies with fragments of fibulin-4 identified the middle cbEGF-like 
repeat (M domain) and the C-terminal fibulin-type motif (C domain) 
as the domains for binding to ATP7A. No interaction was found with 
the N-terminal domain of fibulin-4, indicating that the ATP7A-binding 
site resides in the M and C domain of fibulin-4 (Fig. 5G). These find-
ings support a model where the N-terminal domain of fibulin-4 binds 
the propeptide domain of proLOX and the downstream M and C 
domains interact with ATP7A. In this way, fibulin-4 may function 
as a linker to facilitate direct copper ion transfer from ATP7A to 
proLOX (Fig. 6I).
Secreted fibulin-4 can be internalized by endocytosis 
and contribute to LTQ formation of LOX
An unexpected finding in our studies was the observation that low 
concentration (1 to 2 nM) of recombinant fibulin-4 added to cul-
ture medium reversed the mobility shift of LOX secreted by Fbln4−/− 
MEFs (Fig. 6A). The addition of 8 nM of recombinant fibulin-5, 
however, had no effect, nor did the N, M, or C fragment of fibulin-4 
(fig. S5). Because ATP7A is not located on the cell surface in normal 
medium with low copper concentration (27), this result led us to 
hypothesize that exogenous fibulin-4 can be internalized and trans-
ported to the TGN lumen, where copper ion transfer to proLOX 
occurs (27). To test this hypothesis, we incubated MEF cells with 
recombinant FLAG-tagged fibulin-4 and anti-FLAG antibody at 4°C 
to inhibit internalization of the cell surface–bound protein. The cells 
were then warmed to 37°C to allow internalization of cell surface 
receptor–bound molecules. After acid washing to remove remain-
ing cell surface proteins, internalized fibulin-4 was detected by immuno-
fluorescent staining (Fig. 6, B to E). Internalization was partially 
inhibited by Dynasore, a dynamin inhibitor (28), and Filipin, an in-
hibitor of caveolae-mediated endocytosis (29), suggesting that fibulin-4 
can be internalized by caveolae-mediated endocytosis. We cannot, 
however, exclude the possibility that fibulin-4 can also be internalized 
by clathrin-mediated endocytosis (Fig. 6F). To address whether ex-
ogenous fibulin-4 needs to be internalized to induce LTQ formation 
in LOX produced by Fbln4−/− MEFs, we added Dynasore in the same 
settings as Fig. 6A. The induction of LTQ formation by recombinant 
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WT and Fbln4−/− MEFs. Note delayed migration of mutant LOX proteins even from 
WT MEFs. (B and C) Quinoprotein detection by NBT staining of membrane-transferred 
LOX (B, left) and total protein detection by amido black staining of the same mem-
brane (B, right). BSA (open arrow) was used as a negative control for NBT staining. 
The major lower band of LOX from WT MEFs (closed arrow), the minor lower band 
of LOX from Fbln4−/− MEFs (closed arrowhead), and the major upper band of LOX 
from Fbln4−/− MEFs (open arrowhead) are indicated. The ratio of quantified density 
of each band was shown in (C). Bar graphs show mean ± SEM (n = 4). ***P < 0.001 
compared with WT. (D) Relative quantification of cross-linked peptide derived from 
LTQ formation (left) and non–cross-linked peptide (right) by Orbitrap mass spec-
trometric analysis. The amounts of cross-linked peptide and non–cross-linked pep-
tide were normalized to those of other LOX peptides. Bar graphs show mean ± SEM 
(triplicate measurements). ***P < 0.001.
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fibulin-4 was significantly inhibited by Dynasore (Fig. 6G), and 
the levels of inhibition were comparable to that of endocytosis of 
fibulin-4 by the same concentration of Dynasore (Fig. 6F). Immuno-
fluorescent staining of internalized fibulin-4 and the TGN marker 
Golgin-97 (30) revealed colocalization of these proteins (Fig. 6H). 
The cell surface attachment and the retrograde trafficking to the 
TGN were observed with full-length fibulin-4, but not with the N, 
M, or C fragment of fibulin-4 (fig. S6). These data suggest that some 
of the internalized fibulin-4 reaches the TGN, where copper ion 
transfer to proLOX occurs.
DISCUSSION
In the present study, we identified an essential role for fibulin-4 in 
the activation of LOX. Our proposed model is illustrated in Fig. 6I. 
Fibulin-4 interacts with ATP7A through its middle and C-terminal 
domain and thereby facilitates copper ion transfer from ATP7A to 
N-terminally bound proLOX. Because copper ion bound to specific 
histidine residues of proLOX is necessary for LTQ formation, fibulin-4 
is crucial for generating active LOX. Without fibulin-4, the efficiency 
of copper ion transfer and subsequent LTQ formation are largely 
diminished (Fig. 5E), leading to production of inactive LOX.
We previously reported that the fibulin-4 interacts with LOX 
propeptide and with tropoelastin (21). This potential ability to bridge 
proLOX and tropoelastin could explain a part of the specific role for 
fibulin-4  in elastic fiber assembly; however, it cannot account for 
the nearly identical phenotypes of Fbln4−/− and Lox−/− mice that in-
clude collagen fiber abnormality in addition to elastic fiber deficiency 
(10, 11, 19). Our findings that fibulin-4 is necessary for LOX activity 
and that both elastin and collagen cross-links are greatly reduced in 
Fbln4−/− mouse tissues reconcile this phenotypic similarity.
Sasaki et al. (20) reported that osteoblasts from Fbln4−/− mice 
produce less mature LOX and suggested its mechanism as reduced 
processing of proLOX in the absence of fibulin-4. In our experi-
ments with aortic tissues and MEFs with intact BMP-1, however, we 
did not observe the bands that correspond to unprocessed proLOX, 
in the absence or presence of fibulin-4 (fig. S7). Our data suggest 
that altered processing of proLOX is not a general mechanism by 
which the absence of fibulin-4 affects LOX activity.
In humans, homozygous or compound heterozygous mutations 
in the FBLN4 gene are reported in autosomal recessive cutis laxa 
characterized by loose skin, arterial tortuosity and aneurysms, em-
physema, and skeletal abnormality (31). Among these mutations, 
the E57K missense mutation is located at the N-terminal domain 
and is not assumed to affect the conformation of most of the protein 
(32). Homozygous Fbln4 E57K mutant mice are reported to survive 
to adulthood and exhibit aortic aneurysm, arterial tortuosity, and 
emphysema, which recapitulate the human FBLN4E57K/E57K mutant 
phenotypes (33). Reduced binding of the E57K mutant fibulin-4 
with proLOX (Fig. 1) and weak ability to induce LTQ formation in 
LOX (Fig. 2, B and C) are consistent with the less severe phenotypes 
of human and mouse mutants than those of Fbln4−/− mice.
Among the eight members of the fibulin family, fibulin-3, fibulin-4, 
and fibulin-5 share homology in sequence and domain configura-
tion and are termed “short fibulins” or “elastogenic fibulins” because 
of their size and the phenotypes of the mice deficient in these genes 
(31). Fbln5−/− mice survive to adulthood and show stiff and tortu-
ous arteries, emphysematous lungs, and loose skin, due to defective 
elastogenesis (17, 18). Unlike Fbln4 mutant mice, however, Fbln5−/− 
mice do not show aneurysms. We previously reported that fibulin-5 
promotes coacervation of elastin and recruits elastin onto micro-
fibrils (34). Considering that the loss of fibulin-5 is not compensated 
for by the presence of other fibulins including fibulin-4, these unique 
functions of fibulin-5 in elastic fiber assembly do not overlap with 
those of fibulin-4. Conversely, we reason that the role for fibulin-4 
in the activation of LOX is not shared by other elastogenic fibulins, 
as fibulin-5 cannot interact with proLOX, and loss of fibulin-4 can-
not be compensated for by the presence of other fibulins. However, 
it is possible that fibulin-5 also contributes to the formation of LTQ 
in LOXL1, because fibulin-5 interacts with LOXL1 and LOXL1 plays 
an important role in elastogenesis (12, 34). The function of fibulin-3 
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is not clear, as Fbln3−/− mice show only minor elastic fiber defect in 
fascia (35).
Because the reduced LOX activity has been associated with mu-
tations of the human or mouse ATP7A gene, copper incorporation 
into proLOX is assumed to be mediated by copper transporter 
ATP7A (27). However, a protein that functions to mediate the transfer 
of copper from ATP7A to proLOX has not been anticipated. We 
showed that fibulin-4 promotes copper ion transfer from ATP7A to 
proLOX in the Golgi, which is a necessary step for generation of 
LTQ, a critical cofactor for the oxidase activity. Our studies suggest 
the existence of similar bridging proteins for other copper-dependent 
enzymes, too, such as tyrosinase or peptidylglycine -amidating 
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monooxygenase, enzymes necessary for melanin production or pro-
hormone maturation, respectively (27). How fibulin-4 affects cop-
per transfer is not yet known. We cannot exclude the possibility that 
binding with fibulin-4 alters the conformation of proLOX so that it 
can incorporate copper ion, which does not necessarily contradict 
with the bridging model shown in Fig. 6I. Further study is needed to 
examine this possibility.
The finding that the addition of recombinant fibulin-4 to cell 
culture medium could promote the formation of LTQ in LOX was 
unexpected, because copper transfer to proLOX and subsequent 
LTQ formation occurs in the TGN (27). Very low concentrations (1 
to 2 nM) of fibulin-4 in the medium were sufficient to induce LTQ 
formation in LOX, suggesting that fibulin-4 may work as a circulat-
ing factor for LOX activation. There is a report showing that high 
serum levels of fibulin-4 are associated with ovarian cancer (normal 
~30 ng/ml versus cancer ~300 ng/ml) (36). This reported normal 
level of fibulin-4 (~30 ng/ml = ~0.6 nM) corresponds to a concen-
tration that can partially (~50%) induce LTQ formation in LOX 
(Fig. 6A). Identification of the receptor for fibulin-4 for endocytosis 
and measuring the concentrations of fibulin-4 in circulating blood 
in various ages and in developmental stages require further investi-
gation. It would also be interesting to see whether ectopic expres-
sion of fibulin-4 could rescue the phenotypes of Fbln4−/− mice to 
understand the role for circulating fibulin-4 in vivo.
Together, our results show that fibulin-4 is essential for the for-
mation of enzymatically active LOX and, hence, for elastic fiber for-
mation and collagen fibrillogenesis. Endogenously expressed fibulin-4 
or endocytosed fibulin-4 that is transported to the TGN promotes 
copper ion transfer from ATP7A to proLOX, which is necessary for 
the formation of LTQ, an intramolecular cross-link that works as a 
cofactor for the oxidase activity of LOX (Fig. 6I). Our findings pro-
vide insights into the mechanism of ECM maturation and diseases 
that involve fibrosis or insufficient elastogenesis.
MATERIALS AND METHODS
Mice
All mice used here were maintained on normal laboratory diet. 
Fbln4−/−, Fbln5−/−, and Lox−/− mice were previously described (19, 17, 10) 
and maintained in Kansai Medical University. All procedures were 
approved by the Committee for Animal Experiments of Kansai Medical 
University and conducted according to the Guideline for Animal 
Experimentation at Kansai Medical University.
Antibodies
Primary antibodies used were anti-FLAG (Sigma-Aldrich, F1804), 
anti-Myc and anti-HA (Medical & Biological Laboratories Co., M192-3S 
and M180-3, respectively), anti-LOX (Abcam, ab31238), anti-ATP7A 
(Abcam, ab13995), and anti–Golgin-97 (Cell Signaling Technology, 
13192) antibodies. Secondary antibodies used were horseradish 
peroxidase–conjugated anti-mouse immunoglobulin G (IgG), anti- 
rabbit IgG, and anti-chicken IgY (Abcam, ab205719, ab6721, and 
ab6877, respectively) and Alexa Fluor 488–conjugated anti-mouse 
IgG and Alexa Fluor 555–conjugated anti-rabbit IgG (Thermo Fisher 
Scientific, A-11029 and A-31572, respectively).
Cell culture and genome editing
MEFs and 293T cells were maintained in Advanced DMEM 
(Dulbecco’s modified Eagle’s medium) (Thermo Fisher Scientific) 
supplemented with 2 mM glutamine, penicillin/streptomycin 
(100 U/100 mg ml−1), and 5% fetal bovine serum at 37°C in 5% CO2. 
MEFs were harvested from WT and Fbln4−/− mouse embryo and 
immortalized by transferring with human telomere reverse transcrip-
tase cDNA. For the purification of endogenous LOX from MEFs, a 
monoclonal cell line expressing high-level LOX was selected by lim-
iting dilution of immortalized WT MEFs, followed by Fbln4 gene 
deletion using the CRISPR-Cas9 system with double-nicking strat-
egy (37). Fbln4 single-guide RNA (sgRNA) pairs (5′-agagcagcaaa-
gacccgggg-3′ and 5′-ggcgtttctgctgttgctct-3′) were cloned into Bbs 
I–digested plasmid pX335 (42335, Addgene). The plasmids were 
transduced into WT MEFs followed by clonal isolation and expan-
sion. Targeted region was amplified from genomic DNA, and indel 
mutations were validated by Sanger sequencing. Atp7a−/− MEFs 
were generated in the same manner using Atp7a sgRNA pairs (5′- 
aacagtcaggaacacggtat-3′ and 5′-ctgctccactgactctgcct-3′). To obtain 
BMP1−/− 293T cells and Bmp1−/− MEFs, BMP1 sgRNA pairs (5′- 
cgacgacgtggcccagctcg-3′ and 5′-cgaacacactcggccagacc-3′) and Bmp1 
sgRNA pairs (5′-gggccacacccgctccggtc-3′ and 5′-ggggtcatcccgtttgt-
gat-3′) were used, respectively.
Plasmid construction, lentiviral gene transfer, and  
protein purification
FBLN4-WT, FBLN5, and LOX cDNA were subcloned as previously 
described (21, 34). FBLN4-E57K, FBLN4-N1 (Q28-R53), FBLN4-
N2 (D54-V122), FBLN4-N (Q28-V122), FBLN4-M (D123-R314), 
FBLN4-C (C315-F443), Lox-WT, Lox-K314A, Lox-Y349A, Lox-
H283A, Lox-H286A, Lox-H288A, Lox-H290A, Lox-H297A, Fbln4-FL, 
Fbln4-N (Q47-V141), Fbln4-M (D142-R333), Fbln4-C (C334-F462), 
and ATP7A cDNA were amplified by polymerase chain reaction 
(PCR) and subcloned into pENTR/ssHA, pENTR/ssbFLAG, pENTR/
cFLAG, pEF6/ssFLAG, pEF6/ssFLAG-hIgG, pENTR/atgFLAG, and 
pENTR/atgMyc. Atp7a cDNA was synthesized (Thermo Fisher Sci-
entific) to generate silent mutations to stabilize this gene in high-copy 
plasmid during replication in Escherichia coli (38) and subcloned 
into pENTR/atgFLAG. Atp7a-TM1–4 (K794-L1397) and Atp7a- 
TM5–8 (F646-D927) cDNA were amplified by PCR and subcloned 
into pENTR/atgFLAG. YF mutant Lox cDNA, in which all poten-
tially sulfated tyrosine residues (Y177, Y178, Y180, Y181, and Y184) 
of mouse LOX were substituted by phenylalanine residues (25), was 
generated by PCR-based mutagenesis using pENTR-Lox-cFLAG as 
a template. The entry clones were recombined with pLenti6.3 desti-
nation vectors using Gateway Technology (Invitrogen). Lentiviral 
particles were produced via cotransfection of 293T cells with the 
packaging plasmids using PEI MAX (Polysciences). Supernatants 
were collected starting from 40 hours after transfection for 24 to 
48 hours and concentrated using Lenti-X Concentrator (Clontech) 
according to the manufacturer’s instructions. The resulting viral 
pellet was resuspended in culture medium at ~1/10 of the original 
volume, and the viral aliquot was stored frozen. Using Ni-NTA af-
finity resin (Qiagen), recombinant fibulin-4 or fibulin-5 was puri-
fied from serum-free conditioned medium of 293T cells stably 
expressing fibulin-4 or fibulin-5 with N-terminal His-tags (21, 34).
In vitro binding assay
293T cells were transfected with the plasmids using PEI MAX (Poly-
sciences). The transfected cells were cultured in serum-free DMEM/
F12 (Thermo Fisher Scientific). The conditioned medium (proLOX) 
or the cell lysates (ATP7A) and fibulin-4 and its mutants (recombinant 
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protein or conditioned medium) were mixed and subjected to im-
munoprecipitation with anti-FLAG M2 affinity gel (Sigma-Aldrich) 
followed by SDS-PAGE with NuPAGE Bis-Tris acrylamide gel (4 to 
12%) and MOPS or MES buffer (Thermo Fisher Scientific) and Western 
blotting as described previously (39). N-terminal FLAG-tagged 
bacterial alkaline phosphatase (FLAG-BAP) fusion protein was pur-
chased from Sigma-Aldrich.
Immunodetection of endogenous and FLAG-tagged LOX
Proteins were extracted from mouse neonatal aorta tissues with 8 M 
urea solution, and supernatants were collected. Equal loadings of pro-
tein extracts were subjected to SDS-PAGE with NuPAGE Bis-Tris 
acrylamide gel (4 to 12%) and MES buffer (Thermo Fisher Scientific), 
followed by Western blotting. Cultured MEFs were infected by len-
tiviral particles with the volume adjusted individually to secrete equiv-
alent amount of recombinant proteins. The supernatants of MEFs 
were replaced by serum-free Advanced DMEM/F12 (Thermo Fisher 
Scientific) on the next day of infection and harvested at 48 to 72 hours 
after replacement. The endogenous and FLAG-tagged LOX in the 
medium were concentrated using DEAE Sepharose Fast Flow (GE 
Healthcare), followed by SDS-PAGE with NuPAGE Bis-Tris acryl-
amide gel (4 to 12%) and MES buffer (Thermo Fisher Scientific) and 
Western blotting. For quantification, blots were scanned, and the 
integral density of specific bands was measured using Image Gauge 
Ver. 4.22.
Purification of endogenous LOX and N-terminal amino  
acid sequence
For the purification of endogenous mature LOX from the culture 
medium, DEAE Sepharose Fast Flow was added to the medium. After 
several hours of incubation followed by washing, the DEAE-bound 
LOX was eluted by 1 M NaCl and 6 M urea in 10 mM phosphate 
buffer (PB). The eluates were dialyzed with PB, followed by separa-
tion using Sephacryl S-200 HR (GE Healthcare) that works as an 
affinity column for LOX (40). After washing, LOX was eluted with 
6 M urea in PB. The eluates were concentrated by ultrafiltration. The 
concentration of purified LOX was quantified as described previ-
ously (39).
Purified LOX protein was electrophoresed on a 4 to 12% SDS–
polyacrylamide gel and then transferred onto a polyvinylidene di-
fluoride (PVDF) membrane operated at 30 V for 1 hour. After the 
membrane was stained with SimplyBlue SafeStain (Thermo Fisher 
Scientific), the purified LOX band was excised and analyzed using a 
PPSQ-33A amino acid sequencer system (Shimadzu).
Enzymatic activity measurement of LOX
Rates of oxidation of peptidyl lysine were assessed using the tritiated 
recombinant human tropoelastin as substrates, as described previ-
ously (41) with some modifications. Plasmids encoding human tropo-
elastin cDNA (pTrc His3-hELN) were transformed into One Shot 
Stbl3 Chemically Competent E. coli (Thermo Fisher Scientific). A 
10-ml aliquot of an overnight culture of bacteria was diluted in 90 ml 
of LB medium containing ampicillin (50 g ml−1), and the freshly 
inoculated culture was incubated with shaking at 37°C overnight. 
The cells were collected and washed twice with phosphate-buffered 
saline (PBS) by centrifugation; the cell pellet was suspended in 160 ml 
of lysine-free RPMI 1640 medium (Sigma-Aldrich) with 1.15 mM 
arginine, 0.38 mM leucine, [L-4,5-3H]lysine (1.6 mCi/liter; 80 to 110 Ci 
mmol−1), and 2 mM isopropyl--d(−)-thiogalactopyranoside (Wako 
Pure Chemical) and incubated in this medium with shaking at 37°C 
for 8 hours. The labeled cells were isolated by centrifugation and 
dissolved in 8 M urea/PBS (pH 7.4) with stirring overnight at 4°C. 
The suspension was centrifuged (10,000g, 30 min, 4°C), and the super-
natant was loaded onto a HisTrap FF (GE Healthcare Life Sciences) 
equilibrated with binding buffer [8 M urea/PBS (pH 7.4)] at 5.0 ml/min. 
The bound protein was eluted with elution buffer (binding buffer 
containing 200 mM imidazole). The eluate was dialyzed overnight 
against PBS with Slide-A-Lyzer Dialysis Cassette 10K MWCO (Thermo 
Fisher Scientific), concentrated to 20,000 cpm/l using Amicon Ultra 
30K centrifugal filter devices (Merck Millipore), and used for lysine 
oxidation assay.
Assay mixtures included purified LOX protein and 200,000 cpm 
of the elastin substrate suspended or dissolved in 0.1 M sodium bo-
rate and 0.15 M NaCl (pH 8.0) in a total volume of 0.8 ml and were 
incubated for 2 hours at 37°C. Tritiated water formed during the 
incubation was isolated from the elastin substrate by the trichloro-
acetic acid precipitation method, and radioactivity in 0.7-ml aliquot 
of the supernatants was quantified by liquid scintillation spectrom-
etry. The radioactivity was corrected for each enzyme-free control, 
and all enzyme activities in the assay mixtures were ≥90% inhibited 
by the inclusion of 50 M -aminopropionitrile, a specific inhibitor 
of LOX.
Collagen and elastin cross-link analysis
The dissected aortae (n = 5 per genotype; four samples were pooled 
for a single analysis) were subjected to amino acid analysis and elas-
tin and collagen cross-link analyses as described (42). Briefly, the 
samples were pulverized in liquid nitrogen, washed with cold PBS 
and cold distilled water by repeated centrifugation at 4000g for 30 min, 
and lyophilized. An aliquot of each (∼2 mg) was hydrolyzed with 
6 N HCl and subjected to amino acid analysis. Desmosine and isodes-
mosine were quantified as residues per 1000 amino acids based on 
the commercially available standards. Aliquots of the hydrolysates 
with known amounts of hydroxyproline were also subjected to col-
lagen cross-link analysis. The major nonreducible cross-link pyrid-
inoline was quantified as moles/mole of collagen.
NBT and amido black staining of the membrane
For NBT staining, the PVDF membrane with transferred protein 
was immersed in 0.24 mM NBT (Wako Pure Chemical) in 2 M po-
tassium glycinate solution (pH 10.0) for 45  min in the dark. For 
amido black staining, the membrane was stained with 0.1% amido 
black (Wako Pure Chemical) in 45% methanol/10% acetic acid for 
1 min, followed by destaining with 90% methanol/2% acetic acid 
three times for 1 min each. The intensity of stained bands was quan-
tified using ImageJ software [National Institutes of Health (NIH), 
Bethesda, MD].
Detection and quantification of cross-linked and  
non–cross-linked fragment of LOX
Purified LOX was incubated with 1 mM phenylhydrazine at 25°C 
for 1 hour and 37°C for 30 min, followed by dialysis with 2 M urea 
in PB. After adding ammonium bicarbonate to a concentration of 
50 mM to 0.2 g of LOX solution, disulfide bonds were reduced by 
adding dithiothreitol to a concentration of 50 mM and incubating 
at 56°C for 1 hour. Subsequently, free sulfhydryl groups were al-
kylated by adding iodoacetamide to a concentration of 50 mM and 
incubating at 25°C for 1 hour. After these modifications, protein 
 on January 11, 2021
http://advances.sciencem
ag.org/
D
ow
nloaded from
 
Noda et al., Sci. Adv. 2020; 6 : eabc1404     25 November 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
9 of 10
digestion with Asp-N (Takara Bio) and Trypsin/Lys-C Protease Mix 
(Thermo Fisher Scientific) was performed. To stop digestion, triflu-
oroacetic acid was added to a concentration of 1%.
The ultra-high performance liquid chromatography–MS/MS 
analysis was performed on Q Exactive HF-X Hybrid Quadrupole- 
Orbitrap Mass Spectrometer (Thermo Fisher Scientific) equipped 
with Easy-nLC 1200 (Thermo Fisher Scientific). Chromatographic 
separation of targeted analytes was achieved on PepMap100 C18 LC 
Column (75-m inner diameter, 3-m particle, 100-Å pore size; 
Thermo Fisher Scientific). Solvent A contained 0.1% formic acid, 
and solvent B contained 80% acetonitrile and 0.1% formic acid. 
Peptides were separated through a solvent B gradient from 4 to 
100% within 75 min at a flow rate of 0.3 l/min. Using MS/MS analysis, 
we determined that two peaks of mass/charge ratio (m/z) 994.9440 
(+2) and 663.6318 (+3) were derived from cross-linked peptide 
VAEGHKASFCLE-DTYAA with modification of phenylhydrazine 
labeling and carbamidomethylation on cysteine, and a peak of m/z 
695.8256 (+2) was derived from non–cross-linked peptide VAE-
GHKASFCLE with modification of carbamidomethylation on cys-
teine and carbamylation on lysine. To evaluate the total amount of 
LOX for normalization, we selected seven peptides: DYGYHR (+2), 
m/z 405.67987; DYTNNVVR (+2), m/z 490.74481; DFLPSRPR 
(+2), m/z 494.2746; DEFSHY (+2), m/z 399.15863; DVQPGNYILK 
(+2), m/z 573.81238; DPYYIQASTYVQK (+2), m/z 788.38885; and 
NRPGYGTGYFQYGLP (+2), m/z 845.40326. Relative intensity of 
each peak was quantified by targeted single ion monitoring using 
extracted ion chromatography. Peak area of each ion was measured 
in triplicate. Relative intensities of cross-linked and non–cross-linked 
peptides were normalized to the average intensities of the seven LOX 
peptides.
Determination of Cu concentration by ICP-MS
A 30-l aliquot of samples was wet-ashed with 50 l of nitric acid 
(analytical grade, Wako Pure Chemical Industries) on a hot plate. 
The samples were then diluted with 1% nitric acid to 300 l, fol-
lowed by measurement using an inductively coupled plasma mass 
spectrometer (ICP-MS; Agilent 8800, Agilent Technologies). The 
signal intensities of Cu were monitored at m/z 65 with the integra-
tion time of 0.1 s, and the Cu concentration was calculated using a 
standard calibration method.
Immunocytochemistry
Fbln4−/− MEFs were seeded on a glass-bottom dish. The next day, 
the cells were incubated with culture medium containing recombi-
nant FLAG-FBLN4 (40 nM) with or without endocytosis inhibitors 
Dynasore (Santa Cruz Biotechnology) and Filipin (LKT Laborato-
ries). The inhibitors were present in all steps except for the washing 
buffer. After 3 hours of incubation, the cells were placed on ice and 
washed with ice-cold PBS. After 5 min, the cell surface–bound FLAG- 
FBLN4 was labeled by incubating the cells with ice-cold culture me-
dium containing anti-FLAG antibody. After incubation for 30 min 
on ice, the cells were washed twice with ice-cold PBS and then incu-
bated with warm culture medium at 37°C to allow the internaliza-
tion. The internalization was stopped by placing the cells on ice and 
washing with ice-cold PBS. To remove uninternalized cell surface–
bound antibodies, the cells were washed with ice-cold acid wash 
buffer containing 50 mM glycine and 150 mM NaCl (pH 2.0) for 
1 min, followed by washing with PBS to neutralize the pH. The cells 
were then fixed with 4% paraformaldehyde, washed with PBS, per-
meabilized with 1% Triton X-100, and blocked with 5% bovine 
serum albumin (BSA)/PBS for 1 hour. To visualize cell surface 
and internalized anti-FLAG antibody bound to FLAG-FBLN4, a 
fluorescence-conjugated secondary antibody was used. The cells 
were observed using a BZ-9000 microscope (Keyence) and an LSM 
700 microscope (Zeiss). Intensity of the signal was quantified using 
ArrayScan VTI (Thermo Fisher Scientific).
Statistics
Comparisons were made using Student’s t test between two groups. 
Analyses across multiple groups were made using a one-way analysis 
of variance (ANOVA) with Dunnett’s multiple comparisons post 
hoc test. P values less than 0.05 were considered to be significant.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/48/eabc1404/DC1
View/request a protocol for this paper from Bio-protocol.
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